Ashraf Dower
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ashraf Dower has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Carolina Buenaño Núñez
Hospital de Especialidades Eugenio Espejo. Quito. Pichincha. Ecuador
3 shared publications Benedict Ng
3 shared publications- Caroline Elizabeth Ford
UNSW Sydney, School of Clinical Medicine, Sydney, NSW, Australia
3 shared publications Chau-To Kwok
3 shared publicationsDeborah Packham
3 shared publications- Dominik Beck
Centre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia
3 shared publications
Latest Publications
- 1 December 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (12) , E500-E502
Surgical Decompression for Malignant Cerebral Edema After Ischemic Stroke: Cochrane Review
- 1 December 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (12) , E500-E502
Surgical Decompression for Malignant Cerebral Edema After Ischemic Stroke: Cochrane Review
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Methods, Figures 1-6 Supplemental Tables 1-2 from Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors
Supplementary Figure S1. LSTs profiled in this study. Supplementary Figure S2. Mutation validation by Sanger sequencing. Supplementary Figure S3. Analytical strategy for identifying LST driver genes and significantly altered pathways. Supplementary Figure S4. Comparison of methylation events in LSTs and CRCs. Supplementary Figure S5. Epigenetic inactivation of SLITRK5 occurs frequently in LSTs and CRC cell lines. Supplementary Figure S6. Surface morphology and histopathological subtype correlates with the frequency of KRAS mutations. Supplementary Table S1. Clinicopathological characteristics of the eleven LSTs profiled in this study. Supplementary Supplementary Table S2. Clinicopathological characteristics of Validation Cohorts 1 and 2. Supplementary Table S3. Whole exome sequencing data. Supplementary Table S4. Summary of epigenetic and gene expression data.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods, Figures 1-6 Supplemental Tables 1-2 from Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors
Supplementary Figure S1. LSTs profiled in this study. Supplementary Figure S2. Mutation validation by Sanger sequencing. Supplementary Figure S3. Analytical strategy for identifying LST driver genes and significantly altered pathways. Supplementary Figure S4. Comparison of methylation events in LSTs and CRCs. Supplementary Figure S5. Epigenetic inactivation of SLITRK5 occurs frequently in LSTs and CRC cell lines. Supplementary Figure S6. Surface morphology and histopathological subtype correlates with the frequency of KRAS mutations. Supplementary Table S1. Clinicopathological characteristics of the eleven LSTs profiled in this study. Supplementary Supplementary Table S2. Clinicopathological characteristics of Validation Cohorts 1 and 2. Supplementary Table S3. Whole exome sequencing data. Supplementary Table S4. Summary of epigenetic and gene expression data.
- 16 November 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (11) , CD014989
Surgical decompression for malignant cerebral oedema after ischaemic stroke
Background Large territory middle cerebral artery (MCA) ischaemic strokes account for around 10% of all ischaemic strokes and have a particularly devastating prognosis when associated with malignant oedema. Progressive cerebral oedema starts developing in the first 24 to 48 hours of stroke ictus with an associated rise in intracranial pressure. The rise in intracranial pressure may eventually overwhelm compensatory mechanisms leading to a cascading secondary damage to surrounding unaffected parenchyma. This downward spiral can rapidly progress to death or severe neurological disability. Early decompressive craniectomy to relieve intracranial pressure and associated tissue shift can help ameliorate this secondary damage and improve outcomes. Evidence has been accumulating of the benefit of early surgical decompression in stroke patients. Earlier studies have excluded people above the age of 60 due to associated poor outcomes; however, newer trials have included this patient subgroup. This review follows a Cochrane Review published in 2012. Objectives To assess the effectiveness of surgical decompression in people with malignant oedema after ischaemic stroke with regard to reduction in mortality and improved functional outcome. We also aimed to examine the adverse effects of surgical decompression in this patient cohort. Search methods We searched the Cochrane Stroke Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 7 of 12), MEDLINE Ovid, Embase Ovid, Web of Science Core Collection, Scopus databases, ClinicalTrials.gov, and the WHO ICTRP to July 2022. We also reviewed the reference lists of relevant articles. Selection criteria We included randomised controlled trials (RCTs) comparing decompressive craniectomy with medical management to best medical management alone for people with malignant cerebral oedema after MCA ischaemic stroke. Data collection and analysis Two review authors independently screened the search results, assessed study eligibility, performed risk of bias assessment, and extracted the data. The primary outcomes were death and death or severe disability (modified Rankin Scale (mRS) > 4) at 6 to 12 months follow‐up. Other outcomes included death or moderate disability (mRS > 3), severe disability (mRS = 5), and adverse events. We assessed the certainty of the evidence using the GRADE approach, categorising it as high, moderate, low, or very low. Main results We included nine RCTs with a total of 513 participants included in the final analysis. Three studies included patients younger than 60 years of age; two trials accepted patients up to 80 years of age; and one trial only included patients 60 years or older. The majority of included trials (six) mandated a time from stroke ictus to treatment of < 48 hours, whilst in two of them this was < 96 hours. Surgical decompression was associated with a reduction in death (odds ratio (OR) 0.18, 95% confidence interval (CI) 0.12 to 0.27, 9 trials, 513 participants, P < 0.001; high‐certainty evidence); death or severe disability (mRS > 4, OR 0.22, 95% CI 0.15 to 0.32, 9 trials, 513 participants, P < 0.001; high‐certainty evidence); and death or moderate disability (mRS > 3, OR 0.34, 95% CI 0.22 to 0.52, 9 trials, 513 participants, P < 0.001; moderate‐certainty evidence). Subgroup analysis did not reveal any significant effect on treatment outcomes when analysing age (< 60 years versus ≥ 60 years); time from stroke ictus to intervention (< 48 hours versus ≥ 48 hours); or dysphasia. There was a significant subgroup effect of time at follow‐up (6 versus 12 months, P = 0.02) on death as well as death or severe disability (mRS > 4); however, the validity of this finding was affected by fewer participant numbers in the six‐month follow‐up subgroup. There was no consistent reporting of per‐participant adverse event rates in any of the included studies, which prevented further analysis. Authors' conclusions Surgical decompression improves outcomes in the management of malignant oedema after acute ischaemic stroke, including a considerable reduction in death or severe disability (mRS > 4) and a reduction in death or moderate disability (mRS > 3). Whilst there is evidence that this positive treatment effect is present in patients > 60 years old, it is important to take into account that these patients have a poorer prospect of functional survival independent of this treatment effect. In interpreting these results it must also be considered that the data demonstrating benefit are drawn from a unique patient subset with profound neurological deficit, reduced level of consciousness, and no pre‐morbid disability or severe comorbidity.
- 16 November 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (11) , CD014989
Surgical decompression for malignant cerebral oedema after ischaemic stroke
Background Large territory middle cerebral artery (MCA) ischaemic strokes account for around 10% of all ischaemic strokes and have a particularly devastating prognosis when associated with malignant oedema. Progressive cerebral oedema starts developing in the first 24 to 48 hours of stroke ictus with an associated rise in intracranial pressure. The rise in intracranial pressure may eventually overwhelm compensatory mechanisms leading to a cascading secondary damage to surrounding unaffected parenchyma. This downward spiral can rapidly progress to death or severe neurological disability. Early decompressive craniectomy to relieve intracranial pressure and associated tissue shift can help ameliorate this secondary damage and improve outcomes. Evidence has been accumulating of the benefit of early surgical decompression in stroke patients. Earlier studies have excluded people above the age of 60 due to associated poor outcomes; however, newer trials have included this patient subgroup. This review follows a Cochrane Review published in 2012. Objectives To assess the effectiveness of surgical decompression in people with malignant oedema after ischaemic stroke with regard to reduction in mortality and improved functional outcome. We also aimed to examine the adverse effects of surgical decompression in this patient cohort. Search methods We searched the Cochrane Stroke Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 7 of 12), MEDLINE Ovid, Embase Ovid, Web of Science Core Collection, Scopus databases, ClinicalTrials.gov, and the WHO ICTRP to July 2022. We also reviewed the reference lists of relevant articles. Selection criteria We included randomised controlled trials (RCTs) comparing decompressive craniectomy with medical management to best medical management alone for people with malignant cerebral oedema after MCA ischaemic stroke. Data collection and analysis Two review authors independently screened the search results, assessed study eligibility, performed risk of bias assessment, and extracted the data. The primary outcomes were death and death or severe disability (modified Rankin Scale (mRS) > 4) at 6 to 12 months follow‐up. Other outcomes included death or moderate disability (mRS > 3), severe disability (mRS = 5), and adverse events. We assessed the certainty of the evidence using the GRADE approach, categorising it as high, moderate, low, or very low. Main results We included nine RCTs with a total of 513 participants included in the final analysis. Three studies included patients younger than 60 years of age; two trials accepted patients up to 80 years of age; and one trial only included patients 60 years or older. The majority of included trials (six) mandated a time from stroke ictus to treatment of < 48 hours, whilst in two of them this was < 96 hours. Surgical decompression was associated with a reduction in death (odds ratio (OR) 0.18, 95% confidence interval (CI) 0.12 to 0.27, 9 trials, 513 participants, P < 0.001; high‐certainty evidence); death or severe disability (mRS > 4, OR 0.22, 95% CI 0.15 to 0.32, 9 trials, 513 participants, P < 0.001; high‐certainty evidence); and death or moderate disability (mRS > 3, OR 0.34, 95% CI 0.22 to 0.52, 9 trials, 513 participants, P < 0.001; moderate‐certainty evidence). Subgroup analysis did not reveal any significant effect on treatment outcomes when analysing age (< 60 years versus ≥ 60 years); time from stroke ictus to intervention (< 48 hours versus ≥ 48 hours); or dysphasia. There was a significant subgroup effect of time at follow‐up (6 versus 12 months, P = 0.02) on death as well as death or severe disability (mRS > 4); however, the validity of this finding was affected by fewer participant numbers in the six‐month follow‐up subgroup. There was no consistent reporting of per‐participant adverse event rates in any of the included studies, which prevented further analysis. Authors' conclusions Surgical decompression improves outcomes in the management of malignant oedema after acute ischaemic stroke, including a considerable reduction in death or severe disability (mRS > 4) and a reduction in death or moderate disability (mRS > 3). Whilst there is evidence that this positive treatment effect is present in patients > 60 years old, it is important to take into account that these patients have a poorer prospect of functional survival independent of this treatment effect. In interpreting these results it must also be considered that the data demonstrating benefit are drawn from a unique patient subset with profound neurological deficit, reduced level of consciousness, and no pre‐morbid disability or severe comorbidity.
- 11 February 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (4) , e162-e163
Microscopic Unilateral Laminotomy for Bilateral Decompression: 2-Dimensional Operative Video
- 11 February 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (4) , e162-e163
Microscopic Unilateral Laminotomy for Bilateral Decompression: 2-Dimensional Operative Video
- Open Access
- 25 August 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (8) , e244136
Computed tomography-occult discoligamentous instability following blunt cervical spine trauma
Plain CT is routinely ordered following blunt trauma of the cervical spine, and performs well in the exclusion of significant bony injuries. MRI is reserved for cases of suspected neural or posterior ligamentous compromise, and when other imaging modalities are contraindicated. There are patients however, with unremarkable radiology, and without suggestive clinical features, who are later found to have significant discoligamentous instability. In this report, we present two such cases. In both instances, worsening neurological symptoms prompted follow-up imaging, that demonstrated interval development of sub-axial cervical spondylolisthesis, requiring surgery and instrumentation. We identify and discuss radiological features that may be associated with occult discoligamentous injury, and highlight them as avenues for future research. These may prove useful in stratifying at-risk patients for further imaging in the acute setting.
- 25 August 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (8) , e244136
Open AccessComputed tomography-occult discoligamentous instability following blunt cervical spine trauma
Plain CT is routinely ordered following blunt trauma of the cervical spine, and performs well in the exclusion of significant bony injuries. MRI is reserved for cases of suspected neural or posterior ligamentous compromise, and when other imaging modalities are contraindicated. There are patients however, with unremarkable radiology, and without suggestive clinical features, who are later found to have significant discoligamentous instability. In this report, we present two such cases. In both instances, worsening neurological symptoms prompted follow-up imaging, that demonstrated interval development of sub-axial cervical spondylolisthesis, requiring surgery and instrumentation. We identify and discuss radiological features that may be associated with occult discoligamentous injury, and highlight them as avenues for future research. These may prove useful in stratifying at-risk patients for further imaging in the acute setting.
- 7 July 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (7)
Surgical decompression for malignant cerebral oedema after ischaemic stroke
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness of surgical decompression in patients with malignant oedema after ischaemic stroke with regards to reduction in mortality and improved functional survival. We also aim to examine the adverse effects of surgical decompression in this patient cohort.
- 7 July 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (7)
Surgical decompression for malignant cerebral oedema after ischaemic stroke
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness of surgical decompression in patients with malignant oedema after ischaemic stroke with regards to reduction in mortality and improved functional survival. We also aim to examine the adverse effects of surgical decompression in this patient cohort.
- 1 August 2019
- Published by Elsevier in World Neurosurgery
- Vol. 128, 114-121
Pathologic Basis of Lumbar Radicular Pain
- 1 August 2019
- Published by Elsevier in World Neurosurgery
- Vol. 128, 114-121
Pathologic Basis of Lumbar Radicular Pain
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, 403-406
Spontaneous Acute Arterial Subdural Hematoma
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, 403-406
Spontaneous Acute Arterial Subdural Hematoma